J. Poolman and R. Borrow, Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines, Expert Rev Vaccines, vol.10, issue.3, pp.307-322, 2011.
DOI : 10.1586/erv.11.8

C. N. Kotton and P. L. Hibberd, Travel medicine and transplant tourism in solid organ transplantation, Am J Transplant, vol.13, pp.337-347, 2013.
DOI : 10.1111/ajt.12125
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.12125

, Meningococcal conjugate vaccines policy update: booster dose recommendations, Pediatrics, vol.128, issue.6, pp.1213-1218, 2011.

B. Wyplosz, C. Burdet, and H. Francois, Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation, Am J Transplant, vol.13, issue.9, pp.2458-2461, 2013.
DOI : 10.1111/ajt.12338
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.12338

R. Borrow, P. Balmer, and E. Miller, Meningococcal surrogates of protection--serum bactericidal antibody activity, Vaccine, vol.23, pp.2222-2227, 2005.

F. Caron, I. P. Du-chatelet, and J. P. Leroy, From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak, Lancet Infect Dis, vol.11, issue.6, pp.455-463, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02083160

D. Stamboulian, G. Lopardo, and P. Lopez, Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America, Int J Infect Dis, vol.14, issue.10, pp.868-875, 2010.

M. D. Snape, D. F. Kelly, and S. Lewis, Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study, Bmj, vol.336, issue.7659, pp.1487-1491, 2008.

Y. Sp and D. A. Caugant, Neisseria meningitidis: an overview of the carriage state, J Med Microbiol, vol.53, pp.821-832, 2004.

P. Balmer, M. Falconer, and P. Mcdonald, Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals, Infect Immun, vol.72, issue.1, pp.332-337, 2004.

A. Meerveld-eggink, O. De-weerdt, and R. M. De-voer, Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients, Eur J Clin Microbiol Infect Dis, vol.30, issue.5, pp.611-618, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00654946

J. W. Yu, A. Borkowski, L. Danzig, S. Reiter, P. Kavan et al., Immune response to conjugated meningococcal C vaccine in pediatric oncology patients, Pediatr Blood Cancer, vol.49, issue.7, pp.918-923, 2007.

G. K. Siberry, P. L. Williams, and J. Lujan-zilbermann, Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents, Pediatr Infect Dis J, vol.29, issue.5, pp.391-396, 2010.

M. Zlamy, J. Elias, and U. Vogel, Immunogenicity of conjugate meningococcus C vaccine in pediatric solid organ transplant recipients, Vaccine, vol.29, issue.37, pp.6163-6166, 2011.

E. Zonneveld-huijssoon, A. Ronaghy, and M. A. Van-rossum, Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis, Arthritis Rheum, vol.56, issue.2, pp.639-646, 2007.

S. R. Patel, M. Ortin, and B. J. Cohen, Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation, Clin Infect Dis, vol.44, issue.5, pp.625-634, 2007.